Get started
Author

Rohit Puskoor

Observed institution: Pinnacle Clinical Research
OpenAlex ID: A5134299407
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography ( GOLDMINE ): A Multi‐Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes
2026 · Suzanne Sharpton, Luis Antonio Díaz, et al. · Alimentary Pharmacology & Therapeutics · 7
The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial
2026 · Mazen Noureddin, Winston Dunn, et al. · ˜The œLancet. Gastroenterology & hepatology · 2
TOP-064 Development and validation of a highly accurate noninvasivebased model to predict cirrhosis due to MASH (cirrhosis-7 score)
2026 · Mazen Noureddin, Elizabeth Brombosz, et al. · Journal of Hepatology · 1
LBP-029 Weight loss–independent Glucagon effect led to rapid, clinically significant reductions in MASH severity, including steatosis and liver stiffness, during a 48-week randomized controlled trial of dual agonist DD01
2026 · Mazen Noureddin, Rashmee Patil, et al. · Journal of Hepatology
TOP-066 Machine learning–based models with and without VCTE improve prescreening for at-risk MASH compared with FAST in the largest clinical trial validation cohort
2026 · Winston Dunn, Mazen Noureddin, et al. · Journal of Hepatology
OS-019 Utility of noninvasive criteria based on vibration controlled transient elastography and enhanced liver fibrosis test in identifying patients with high-risk MASLD
2026 · Naim Alkhouri, Elizabeth Brombosz, et al. · Journal of Hepatology
TOP-082 Machine learning–based models with and without VCTE improve cirrhosis prescreening compared with Agile4 and VCTE in the largest clinical trial validation cohort
2026 · Winston Dunn, Naim Alkhouri, et al. · Journal of Hepatology
Works count: 7
Citation count: 10
H-index: 2
I10-index:
Year
Topic
Type